NASDAQ:CBIO | Insider Transactions — Page 2 | CRESCENT BIOPHARMA, INC.

CBIO Insider Transactions — Page 2

296 retained open-market purchase and sale rows from SEC Forms 3, 4 and 5, newest first. This page shows rows 101–200; provenance stays internal.

Insider profileRoleDateTransactionSharesPrice
Artal Group S.A.TenPercentOwner2023-02-17Purchase200,000.0$1.71
Artal International S.C.A.TenPercentOwner2023-02-17Purchase200,000.0$1.71
Westend S.A.TenPercentOwner2023-02-17Purchase200,000.0$1.71
Invus Public Equities Advisors, LLCTenPercentOwner2023-02-17Purchase200,000.0$1.71
Invus Public Equities, L.P.TenPercentOwner2023-02-17Purchase200,000.0$1.71
Stichting Administratiekantoor WestendTenPercentOwner2023-02-17Purchase200,000.0$1.71
Artal International Management S.A.TenPercentOwner2023-02-17Purchase200,000.0$1.71
Wittouck AmauryTenPercentOwner2023-02-17Purchase200,000.0$1.71
Artal Group S.A.TenPercentOwner2023-02-16Purchase315,266.0$1.68
Artal International S.C.A.TenPercentOwner2023-02-16Purchase315,266.0$1.68
Westend S.A.TenPercentOwner2023-02-16Purchase315,266.0$1.68
Invus Public Equities Advisors, LLCTenPercentOwner2023-02-16Purchase315,266.0$1.68
Invus Public Equities, L.P.TenPercentOwner2023-02-16Purchase315,266.0$1.68
Stichting Administratiekantoor WestendTenPercentOwner2023-02-16Purchase315,266.0$1.68
Artal International Management S.A.TenPercentOwner2023-02-16Purchase315,266.0$1.68
Wittouck AmauryTenPercentOwner2023-02-16Purchase315,266.0$1.68
Artal Group S.A.TenPercentOwner2023-02-15Purchase1,000,000.0$2.16
Artal International S.C.A.TenPercentOwner2023-02-15Purchase1,000,000.0$2.16
Westend S.A.TenPercentOwner2023-02-15Purchase1,000,000.0$2.16
Invus Public Equities Advisors, LLCTenPercentOwner2023-02-15Purchase1,000,000.0$2.16
Invus Public Equities, L.P.TenPercentOwner2023-02-15Purchase1,000,000.0$2.16
Stichting Administratiekantoor WestendTenPercentOwner2023-02-15Purchase1,000,000.0$2.16
Artal International Management S.A.TenPercentOwner2023-02-15Purchase1,000,000.0$2.16
Wittouck AmauryTenPercentOwner2023-02-15Purchase1,000,000.0$2.16
Artal Group S.A.TenPercentOwner2023-02-09Purchase11,451.0$3.24
Artal International S.C.A.TenPercentOwner2023-02-09Purchase11,451.0$3.24
Westend S.A.TenPercentOwner2023-02-09Purchase11,451.0$3.24
Invus Public Equities Advisors, LLCTenPercentOwner2023-02-09Purchase11,451.0$3.24
Invus Public Equities, L.P.TenPercentOwner2023-02-09Purchase11,451.0$3.24
Stichting Administratiekantoor WestendTenPercentOwner2023-02-09Purchase11,451.0$3.24
Artal International Management S.A.TenPercentOwner2023-02-09Purchase11,451.0$3.24
Wittouck AmauryTenPercentOwner2023-02-09Purchase11,451.0$3.24
SANDELL SCOTT DTenPercentOwner2023-01-26Sale1,351,092.0$3.12
SANDELL SCOTT DTenPercentOwner2023-01-26Sale1,648,908.0$3.12
SANDELL SCOTT DTenPercentOwner2023-01-25Sale293,645.0$3.26
SANDELL SCOTT DTenPercentOwner2023-01-25Sale358,371.0$3.26
SANDELL SCOTT DTenPercentOwner2023-01-05Sale32,139.0$2.76
SANDELL SCOTT DTenPercentOwner2023-01-05Sale39,223.0$2.76
SANDELL SCOTT DTenPercentOwner2023-01-04Sale45,930.0$2.91
SANDELL SCOTT DTenPercentOwner2023-01-04Sale56,054.0$2.91
SANDELL SCOTT DTenPercentOwner2023-01-03Sale78,730.0$2.99
SANDELL SCOTT DTenPercentOwner2023-01-03Sale96,084.0$2.99
SANDELL SCOTT DTenPercentOwner2022-12-30Sale54,645.0$3.02
SANDELL SCOTT DTenPercentOwner2022-12-30Sale66,690.0$3.02
Rock EdwinChief Medical Officer2022-12-22Purchase110,000.0$2.25
JUNIUS DANIEL MDirector2022-11-17Purchase20,000.0$1.87
Rock EdwinChief Medical Officer2022-11-15Purchase100,000.0$1.66
Rock EdwinChief Medical Officer2022-11-14Purchase100,000.0$1.43
PEARSON TIMOTHY RDirector2022-11-11Purchase19,400.0$1.29
Semerjian HaroutChief Executive Officer2022-11-11Purchase25,000.0$1.29
Hahn Brian M.SVP Finance, CFO2022-11-11Purchase20,000.0$1.06
Magnani John L.SVP of Research, CSO2022-11-11Purchase45,045.0$1.17
Girard ArmandSVP, Chief Business Officer2022-11-11Purchase6,500.0$1.05
Magnani John L.SVP of Research, CSO2022-03-09Sale3,227.0$1.09
Girard ArmandSVP, Chief Business Officer2022-03-09Sale2,339.0$1.09
Hahn Brian M.SVP Finance, CFO2022-03-09Sale2,917.0$1.09
Andrews Patricia SDirector2021-11-16Purchase40,000.0$2.05
King Rachel K.President, CEO2020-12-28Sale84,176.0$3.91
BIOTECHNOLOGY VALUE FUND L PTenPercentOwner2020-11-04Purchase86,090.0$2.6
BVF PARTNERS L P/ILTenPercentOwner2020-11-04Purchase86,090.0$2.6
BVF INC/ILTenPercentOwner2020-11-04Purchase86,090.0$2.6
BIOTECHNOLOGY VALUE FUND II LPOther2020-11-04Purchase86,090.0$2.6
LAMPERT MARK NTenPercentOwner2020-11-04Purchase86,090.0$2.6
Biotechnology Value Trading Fund OS LPOther2020-11-04Purchase86,090.0$2.6
BVF Partners OS Ltd.Other2020-11-04Purchase86,090.0$2.6
BVF I GP LLCTenPercentOwner2020-11-04Purchase86,090.0$2.6
BVF II GP LLCOther2020-11-04Purchase86,090.0$2.6
BVF GP HOLDINGS LLCTenPercentOwner2020-11-04Purchase86,090.0$2.6
BIOTECHNOLOGY VALUE FUND L PTenPercentOwner2020-11-04Purchase506,155.0$2.6
BVF PARTNERS L P/ILTenPercentOwner2020-11-04Purchase506,155.0$2.6
BVF INC/ILTenPercentOwner2020-11-04Purchase506,155.0$2.6
BIOTECHNOLOGY VALUE FUND II LPOther2020-11-04Purchase506,155.0$2.6
LAMPERT MARK NTenPercentOwner2020-11-04Purchase506,155.0$2.6
Biotechnology Value Trading Fund OS LPOther2020-11-04Purchase506,155.0$2.6
BVF Partners OS Ltd.Other2020-11-04Purchase506,155.0$2.6
BVF I GP LLCTenPercentOwner2020-11-04Purchase506,155.0$2.6
BVF II GP LLCOther2020-11-04Purchase506,155.0$2.6
BVF GP HOLDINGS LLCTenPercentOwner2020-11-04Purchase506,155.0$2.6
BIOTECHNOLOGY VALUE FUND L PTenPercentOwner2020-11-04Purchase674,492.0$2.6
BVF PARTNERS L P/ILTenPercentOwner2020-11-04Purchase674,492.0$2.6
BVF INC/ILTenPercentOwner2020-11-04Purchase674,492.0$2.6
BIOTECHNOLOGY VALUE FUND II LPOther2020-11-04Purchase674,492.0$2.6
LAMPERT MARK NTenPercentOwner2020-11-04Purchase674,492.0$2.6
Biotechnology Value Trading Fund OS LPOther2020-11-04Purchase674,492.0$2.6
BVF Partners OS Ltd.Other2020-11-04Purchase674,492.0$2.6
BVF I GP LLCTenPercentOwner2020-11-04Purchase674,492.0$2.6
BVF II GP LLCOther2020-11-04Purchase674,492.0$2.6
BVF GP HOLDINGS LLCTenPercentOwner2020-11-04Purchase674,492.0$2.6
BIOTECHNOLOGY VALUE FUND L POther2020-10-30Purchase15,472.0$2.75
BVF PARTNERS L P/ILTenPercentOwner2020-10-30Purchase15,472.0$2.75
BVF INC/ILTenPercentOwner2020-10-30Purchase15,472.0$2.75
BIOTECHNOLOGY VALUE FUND II LPOther2020-10-30Purchase15,472.0$2.75
LAMPERT MARK NTenPercentOwner2020-10-30Purchase15,472.0$2.75
Biotechnology Value Trading Fund OS LPOther2020-10-30Purchase15,472.0$2.75
BVF Partners OS Ltd.Other2020-10-30Purchase15,472.0$2.75
BVF I GP LLCOther2020-10-30Purchase15,472.0$2.75
BVF II GP LLCOther2020-10-30Purchase15,472.0$2.75
BVF GP HOLDINGS LLCTenPercentOwner2020-10-30Purchase15,472.0$2.75
BIOTECHNOLOGY VALUE FUND L POther2020-10-30Purchase250,755.0$2.75
BVF PARTNERS L P/ILTenPercentOwner2020-10-30Purchase250,755.0$2.75